Pricing Log in Create free account

Geron Corporation (GERN) vs Cybin Inc. (HELP)

Geron Corporation and Cybin Inc. are both Biotechnology companies. Geron Corporation and Cybin Inc. are of similar size ($807.3M and $790.2M). Cybin Inc. has the higher net margin (0.00% vs −33.1%) and the lower return on invested capital (−137.9% vs −89.9%). Across the 14 metrics below, Geron Corporation leads on 7 and Cybin Inc. on 7.

Valuation

Metric GERN HELP Biotechnology median
P/E n/m n/m 8.50
P/S 3.84 n/m 9.71
P/B 3.59 2.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.29 n/m 9.21
Earnings yield (9.01%) (38.49%) (33.15%)
Free cash flow yield (14.62%) (25.89%) (25.50%)

Profitability

Metric GERN HELP Biotechnology median
Gross margin 93.51% 0.00% 65.16%
Operating margin (25.31%) 0.00% 0.00%
Net margin (33.05%) 0.00% 0.00%
Free cash flow margin (56.10%) 0.00% 0.00%
Return on equity (28.28%) (86.94%) (56.36%)
Return on assets (12.59%) (72.78%) (48.04%)
Return on invested capital (89.85%) (137.88%) 0.00%

Growth

Metric GERN HELP Biotechnology median
Revenue growth (TTM) 24.39% — 6.02%
EPS growth (last fiscal year) 51.85% (5.72%) 30.26%
Revenue growth, 5-year CAGR 273.49% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GERN HELP Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 6.92 10.97 4.72
Net debt to EBITDA 3.28 1.10 0.96

Dividend

Metric GERN HELP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GERN HELP Biotechnology median
Market cap 790.24m 807.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack